CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 target
Drug / intervention
Decipher Questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02034825
NCT02034825N/ACompleted
CompareCT.gov

ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery

GenomeDx Biosciences Corp·observational·Posted Jan 14, 2014·Updated Feb 29, 2016

In Brief

An observational study evaluating Decipher Questionnaire for Prostate Cancer. Completed, enrolled 50 participants across 3 sites.

Detailed Summary

This prospectively designed retrospective clinical utility study will evaluate urologists' treatment recommendations before and after reviewing Decipher results for selected patient cases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsColumbia University

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 14, 2014
Enrollment StartJan 1, 2013
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 12.5 years ago

Interventions

Decipher Questionnaireother

Each participant will complete the pre and post-Decipher eCRQs for a minimum of 5 cases, and a maximum of 25 cases.